Whereas the relationship between subclinical atherosclerosis and antiphospholipid syndrome (APS) has been widely investigated, little is known about subclinical atherosclerosis in asymptomatic carriers with isolated antiphospholipid antibodies positivity (APP).

Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study / Di Minno, Matteo Nicola Dario; Emmi, Giacomo; Ambrosino, Pasquale; Scalera, Antonella; Tufano, Antonella; Cafaro, Giovanni; Peluso, Rosario; Bettiol, Alessandra; Di Scala, Gerardo; Silvestri, Elena; Prisco, Domenico. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - ELETTRONICO. - 274:(2019), pp. 1-6. [10.1016/j.ijcard.2018.06.010]

Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study

Emmi, Giacomo;Bettiol, Alessandra;Di Scala, Gerardo;Silvestri, Elena;Prisco, Domenico
2019

Abstract

Whereas the relationship between subclinical atherosclerosis and antiphospholipid syndrome (APS) has been widely investigated, little is known about subclinical atherosclerosis in asymptomatic carriers with isolated antiphospholipid antibodies positivity (APP).
2019
274
1
6
Di Minno, Matteo Nicola Dario; Emmi, Giacomo; Ambrosino, Pasquale; Scalera, Antonella; Tufano, Antonella; Cafaro, Giovanni; Peluso, Rosario; Bettiol, ...espandi
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1178408
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 32
social impact